FDA approves Lucentis to treat diabetic retinopathy in patients with diabetic macular edema

The U.S. Food and Drug Administration announced today that they have expanded the approved use for Lucentis 0.3 mg (Genentech) to treat diabetic retinopathy in patients with diabetic macular edema. The FDA previously had approved Lucentis to treat DME and macular edema secondary to retinal vein occlusions, both of which cause fluid to leak into [Read More]

Does Calcium Cause AMD?

New research may be misconstrued by Dan Roberts A recent press release from the University of Maryland School of Medicine has found that tiny spherules of calcium phosphate known as hydroxyapatite, or HAP) may be an important “triggering factor” for age-related macular degeneration (AMD). The report appeared in the latest issue of the Proceedings of the National Academy of [Read More]